Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 GlobeNewswire December 23, 2025 Jupiter, Florida, Dec. 23, 2025 (GLOBE NEWSWIRE) — Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL(TM), a patented resveratrol-based platform, is pleased to invite investors to a webinar on January 6, […]

Rezolve Ai Accelerates Global Momentum with Live Enterprise Deployments, Major Renewals and Expanding Pipeline into 2026 Global brands move from pilots to production as Rezolve proves the shift from search to conversation is already underway GlobeNewswire December 23, 2025 NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV) (the “Company” or “Rezolve

MBAK Energy Solutions, Inc. (OTC:MBAK) partners with Carbon Zero Mobility in Kenya and the University of Michigan on Charger Design GlobeNewswire December 23, 2025 SEOUL, South Korea and SHENZHEN, China and WILMINGTON, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) — MBAK Energy Solutions, Inc. (OTC:MBAK) is partnering with the University of Michigan Perot-Jain TechLab (PJTL) and

Outpace Wins 144+ SEO Awards, Establishing Itself as one of the Best SEO Agencies in the US GlobeNewswire December 23, 2025 Oklahoma City, OK, Dec. 23, 2025 (GLOBE NEWSWIRE) — Outpace SEO, a top-rated SEO agency known for its comprehensive digital marketing solutions, has achieved a major milestone by winning more than 144 prestigious SEO

New Research Shows Pressurized Oxygen Therapy's Benefits Beyond Traditional Uses GlobeNewswire December 23, 2025 CHICAGO, IL, Dec. 23, 2025 (GLOBE NEWSWIRE) — A treatment once reserved for scuba divers is gaining attention for its potential in treating a variety of ailments, including traumatic brain injuries, lingering COVID symptoms, and chronic inflammation. Hyperbaric oxygen therapy works

SunPower Q3'25 10Q Report Filed GlobeNewswire December 23, 2025 OREM, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) — SunPower Inc. (herein “SunPower,” the “Company,” or Nasdaq: “SPWR”), a solar technology, services, and installation Company, today announced that its Q3'25 10Q report is posted on the SEC website as of December 19, 2025. SunPower CEO, T.J. Rodgers

Renewal Fuels (RNWF) & Its Subsidiary American Fusion Highlight Near-Term Commercial Fusion Strategy, Underscoring Key Distinctions Between Deployable Energy Infrastructure & Experimental Fusion Programs GlobeNewswire December 23, 2025 LAS VEGAS, Dec. 23, 2025 (GLOBE NEWSWIRE) — Renewal Fuels, Inc. (OTC: RNWF) (“RNWF” or the “Company”), which recently announced the execution of a definitive merger with

JFB Construction Announces 119% Increase in Anticipated Q4 2025 Revenues as Compared with Q4 2024 Revenues GlobeNewswire December 23, 2025 Lantana, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) — JFB Construction Holdings (Nasdaq: JFB), a real estate development and construction company focused on hospitality, commercial, industrial, and residential property development, today announced that it expects Q4

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial GlobeNewswire December 23, 2025 –Plans to double the Number of Patients in Study– –Company Expects Initial Findings to be presented in 2026– BOCA RATON, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a biotech company focused

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia GlobeNewswire December 23, 2025 Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the treatment of schizophrenia Current data package